Bupleurum Chinense Root.
Bupleurum Chinense Root supplementation for targeted health support. Saikosaponins modulate liver function, reduce inflammation, and may affect stress hormones. Traditional use for liver qi stagnation (stress, frustration, hormonal issues).
Reviewed March 2026
- Category
- Tcm
What Bupleurum Chinense Root is, and what it does.
- Does it work
- Strong traditional track record. Modern evidence is supportive but limited. Best as part of formulas.
- How much to take
- 3-12 grams dried root in decoction. Extracts: 500-1500mg.
- Time to feel it
- Nobody has timed this in a controlled trial. Traditional courses run two to four weeks, and any change in tension or digestion tends to appear across that window.
- The first dose
- Subtle or nothing. May notice mild relaxation.
- With regular use
- Improved stress resilience, better digestion, potential liver marker improvements.
- How well tolerated
- Generally well tolerated in traditional doses. Concerns with high-dose long-term use.
- How it feels
- Bitter, earthy and faintly foaming as a decoction. Most people report a gradual loosening of tension across a course rather than anything they can point to on a given day.
- The overlooked benefit
- Vinegar processing isn't decorative. It shifts the saikosaponin profile, so cu chai hu and raw root are different materials even at the same milligram figure on the label.
250 to 500mg a day is where Bupleurum Chinense Root works.
Source: Chinese Pharmacopoeia 2020; Sho-saiko-to formula studies
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Bupleurum Chinense Root has emerging evidence. Based on 21+ studies.
- Hepatoprotective effectsStudies show liver-protective effects at moderate doses
- Reduces stress and frustrationTraditional use supported by stress hormone modulation studies
- Well tolerated at any doseHigh-dose long-term use associated with liver injury in some cases
Questions people ask about Bupleurum Chinense Root.
- What is liver qi stagnation?
- TCM concept: stuck energy causing frustration, sighing, digestive issues, hormonal problems. Western equivalent: stress affecting multiple systems.
- Is it safe for the liver?
- Paradox: protects liver at normal doses but can harm at very high long-term doses. Stick to traditional dosing.
- Can I take it alone?
- Traditionally used in formulas (Xiao Chai Hu Tang, etc.). Alone is less common.
- Does it help with stress?
- Traditional use strongly supports this. Modern research on saikosaponins shows stress-modulating effects.
- Any interactions?
- May interact with medications metabolized by CYP enzymes. Consult before combining with pharmaceuticals.
- Which species is best?
- Bupleurum chinense is the main species. B. falcatum (Korean) is also used. Both have saikosaponins.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Chai hu and huang qin are the two chief herbs of the classic harmonising formula and are almost never used apart in that context. Saikosaponins and baicalin flavones make up the paired chemistry of that preparation.
Gan cao appears in essentially every classical Bupleurum formula, and its glycyrrhizin acts as a natural surfactant that improves dispersion of the poorly soluble saikosaponins. The pairing is both traditional and physicochemical.
Fresh ginger is a standing component of the classic Bupleurum harmonising formula, included to settle the stomach against the bitter cold herbs. It is part of the formula rather than an optional addition.
Jujube is combined with ginger in the same Bupleurum formula as the standard pair that moderates the harshness of the chief herbs. It appears alongside Bupleurum across that whole formula family.
Ren shen sits in the same classical Bupleurum formula, and both herbs are triterpene saponin sources whose glycosides are deglycosylated by gut bacteria before absorption. They are used together as a supporting and chief herb pair.
Bupleurum and Angelica sinensis are the two lead herbs of the classical free-and-easy formula. The combination is standard in that preparation rather than occasional.
Schisandra lignans are well described as modifiers of cytochrome P450 and P-glycoprotein activity, and bupleurum saikosaponins are themselves substrates for hepatic metabolism. Combining them can change how either is cleared, and how co-taken medicines are cleared. This is a pharmacokinetic interaction to account for in a formula, not a benefit claim.
Astragalus and bupleurum are combined in classical tonifying and raising formulas, where astragalus carries the tonic role and bupleurum the moving one. The pairing is documented in materia medica and modern formula analyses. What holds it up is tradition and formula-pattern data, not a head-to-head trial.
Magnolia bark honokiol and magnolol act at GABA-A modulatory sites, and bupleurum is used in formulas aimed at tension and irritability. Stacking two calming botanicals is an additive-sedation consideration worth flagging to anyone also taking something sedating. The combination itself has not been studied.
L-theanine acts on glutamate receptor binding and alpha-wave activity, a different route from anything attributed to saikosaponins. A formulator pairing them is stacking two calm-supporting routes rather than duplicating one. Flagged as additive sedation for completeness; no combination data exists.
Chamomile apigenin binds benzodiazepine sites in preclinical work, and both botanicals show up in blends aimed at evening tension. The pairing is a formulation convention rather than a studied combination. Additive sedation is the practical note.
Rhodiola is studied for effects on the hypothalamic-pituitary-adrenal response to a stressor, while bupleurum's traditional role is described in terms of moving stagnation. They occupy different mechanistic space, which is the argument for combining rather than duplicating. Neither the combination nor a shared endpoint has been trialled.
Ashwagandha withanolides have human data on cortisol markers; bupleurum does not carry that literature. Combining them means one component has marker data and one does not, and a formula should say which is which. Cortisol is a marker, not an outcome.
Silymarin flavonolignans influence phase II conjugation and several transporters, and saikosaponins are cleared hepatically. Putting both in one formula changes the metabolic load on the same pathways. This is a pharmacokinetic note about the pair, not a claim about the organ.
Curcuminoids and saikosaponins both appear in blends aimed at everyday inflammatory balance and both are poorly water soluble. They share a solubility problem more than a mechanism, so the formulation decision matters more than the pairing itself. No combination study supports an added effect.
Reishi and bupleurum appear together in modern blends drawing on Chinese herbal tradition, with reishi contributing beta-glucans and triterpenes. The convention is commercial and traditional rather than trial-derived. Say so on the label rather than implying combined evidence.
Nothing specific on file for Bupleurum Chinense Root. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Bupleurum Chinense Root actually does.
The characteristic constituents of Bupleurum chinense root are saikosaponins, oleanane-type triterpene glycosides. Their sugar chains make them poorly absorbed intact, and gut microbial hydrolysis to the aglycone form is a recognised step before systemic exposure.
Saponins are surface-active by structure, which is why saponin-rich decoctions foam and why saponin content changes how other lipophilic constituents disperse in the same preparation.
Bupleurum root also carries polysaccharides and essential-oil constituents, and water extraction and ethanol extraction recover these fractions in different proportions, which is why two extracts of the same root are not chemically interchangeable.
Saikosaponins are labile to heat and acid, so decoction time, drying temperature and any vinegar or honey processing step alter the saponin profile of the finished material relative to the raw root.
Where Bupleurum Chinense Root comes from.
It is a root. It gets dug up when the plant has gone dormant, washed, dried and either sliced for brewing or simmered and concentrated into an extract powder. Some traditional versions are stir-processed with vinegar first, which changes the chemistry, so raw and processed root are not the same material.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Roots of cultivated or wild Bupleurum chinense, lifted in spring or autumn when the aerial parts have died back. Species substitution within the genus is a known supply issue, so botanical identity testing matters.
Soil is washed off and the roots are sun-dried or hot-air dried. Drying temperature affects the saponin and essential-oil content of the finished root.
Some material is stir-processed with vinegar or honey per pao zhi convention, which changes the saponin profile relative to the raw root.
Hot water recovers saponins and polysaccharides; aqueous ethanol shifts recovery toward the saponin and lipophilic fractions.
The liquor is filtered, concentrated under vacuum to limit heat exposure, and may pass a resin step to raise saponin concentration.
Extracts intended for capsules are assayed by HPLC for saikosaponin a and d and blended to a declared percentage.
Supplied as dried slices for decoction, as spray-dried granules, or as an extract powder filled into capsules.
The forms it comes in.
The essence, in one line each.
- A review of recorded traditional Chinese medicine prescribing patterns in which bupleurum appears among the frequently co-prescribed herbs; the paper describes prescribing convention, not measured effect.Narrative review. Li B et al., 2025 (Neuropsychiatric Disease and Treatment). PMID 40955202 ↗
- A survey of natural compounds discussed in relation to mood and eating behaviour that names bupleurum among the botanicals reviewed; the paper catalogues candidates rather than reporting a result for this root.Narrative review. Ma W et al., 2025 (Nutrients). PMID 40733008 ↗
These are the studies our verdict leans on, chosen from the 2 we read for Bupleurum Chinense Root. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.